151 related articles for article (PubMed ID: 21898382)
21. Importance of TAP-independent processing pathways.
Oliveira CC; van Hall T
Mol Immunol; 2013 Sep; 55(2):113-6. PubMed ID: 23183105
[TBL] [Abstract][Full Text] [Related]
22. A specific cytotoxic T-lymphocyte epitope presentation system for antitumor immunity.
Wu Y; Liu C; Sun M; Shen H; Guo D; Gao B
Int J Cancer; 2010 May; 126(10):2373-86. PubMed ID: 19810094
[TBL] [Abstract][Full Text] [Related]
23. Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation.
Horst D; van Leeuwen D; Croft NP; Garstka MA; Hislop AD; Kremmer E; Rickinson AB; Wiertz EJ; Ressing ME
J Immunol; 2009 Feb; 182(4):2313-24. PubMed ID: 19201886
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
[TBL] [Abstract][Full Text] [Related]
25. Function of the transport complex TAP in cellular immune recognition.
Abele R; Tampé R
Biochim Biophys Acta; 1999 Dec; 1461(2):405-19. PubMed ID: 10581370
[TBL] [Abstract][Full Text] [Related]
26. The Immunogenicity of a Proline-Substituted Altered Peptide Ligand toward the Cancer-Associated TEIPP Neoepitope Trh4 Is Unrelated to Complex Stability.
Hafstrand I; Doorduijn EM; Sun R; Talyzina A; Sluijter M; Pellegrino S; Sandalova T; Duru AD; van Hall T; Achour A
J Immunol; 2018 Apr; 200(8):2860-2868. PubMed ID: 29507106
[TBL] [Abstract][Full Text] [Related]
27. Endogenous TAP-independent MHC-I antigen presentation: not just the ER lumen.
Del Val M; Antón LC; Ramos M; Muñoz-Abad V; Campos-Sánchez E
Curr Opin Immunol; 2020 Jun; 64():9-14. PubMed ID: 31935516
[TBL] [Abstract][Full Text] [Related]
28. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins.
Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F
J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631
[TBL] [Abstract][Full Text] [Related]
29. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
[TBL] [Abstract][Full Text] [Related]
30. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
Hulpke S; Baldauf C; Tampé R
FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
[TBL] [Abstract][Full Text] [Related]
31. Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading.
Tan P; Kropshofer H; Mandelboim O; Bulbuc N; Hämmerling GJ; Momburg F
J Immunol; 2002 Feb; 168(4):1950-60. PubMed ID: 11823531
[TBL] [Abstract][Full Text] [Related]
32. Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma.
Agrawal S; Reemtsma K; Bagiella E; Oluwole SF; Braunstein NS
Cell Immunol; 2004 Apr; 228(2):130-7. PubMed ID: 15219464
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.
Andersen MH; Bonfill JE; Neisig A; Arsequell G; Sondergaard I; Valencia G; Neefjes J; Zeuthen J; Elliott T; Haurum JS
J Immunol; 1999 Oct; 163(7):3812-8. PubMed ID: 10490979
[TBL] [Abstract][Full Text] [Related]
34. Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1(b).
Tompkins SM; Kraft JR; Dao CT; Soloski MJ; Jensen PE
J Exp Med; 1998 Sep; 188(5):961-71. PubMed ID: 9730897
[TBL] [Abstract][Full Text] [Related]
35. New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentation.
Oliveira CC; Querido B; Sluijter M; de Groot AF; van der Zee R; Rabelink MJ; Hoeben RC; Ossendorp F; van der Burg SH; van Hall T
J Immunol; 2013 Oct; 191(8):4020-8. PubMed ID: 24048903
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
37. Assembly of tapasin-associated MHC class I in the absence of the transporter associated with antigen processing (TAP).
Paulsson KM; Anderson PO; Chen S; Sjögren HO; Ljunggren HG; Wang P; Li S
Int Immunol; 2001 Jan; 13(1):23-9. PubMed ID: 11133831
[TBL] [Abstract][Full Text] [Related]
38. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
[TBL] [Abstract][Full Text] [Related]
39. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
Lewis JW; Neisig A; Neefjes J; Elliott T
Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
[TBL] [Abstract][Full Text] [Related]
40. Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP.
Luteijn RD; Hoelen H; Kruse E; van Leeuwen WF; Grootens J; Horst D; Koorengevel M; Drijfhout JW; Kremmer E; Früh K; Neefjes JJ; Killian A; Lebbink RJ; Ressing ME; Wiertz EJ
J Immunol; 2014 Aug; 193(4):1578-89. PubMed ID: 25024387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
